NEW YORK & PETACH TIKVAH, Israel--(BUSINESS WIRE)--BrainStorm Cell Therapeutics Inc. (BCLI.PK or BCLI.QB formerly BCLI.OB), a leading developer of adult stem cell technologies and therapeutics, today provided a review of recent accomplishments for shareholders and investors.
